Beta-Amyloid Precursor Protein (βAPP) Processing in Alzheimer’s Disease (AD) and Age-Related Macular Degeneration (AMD)
Open accessThe DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Abstract
Amyloid is a generic term for insoluble, often intensely hydrophobic, fibrous protein aggregates that arise from inappropriately folded versions of naturally-occurring polypeptides. The abnormal generation and accumulation of amyloid, often referred to as amyloidogenesis, has been associated with the immune and pro-inflammatory pathology of several progressive age-related diseases of the human central nervous system (CNS) including Alzheimer’s disease (AD) and age-related macular degeneration (AMD). This ‘research perspective’ paper reviews some of the research history, biophysics, molecular-genetics and environmental factors concerning the contribution of amyloid beta (Aβ) peptides, derived from beta-amyloid precursor protein (βAPP), to AD and AMD that suggests an extensive similarity in immune and inflammatory degenerative mechanisms between these two CNS diseases.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Amyloid deposition as the central event in the aetiology of Alzheimer’s disease
Hardy, J., & Allsop, D. (1991) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(91)90609-v · Cited by 2,538 · cited 1×
“As for AD, AMD is divided into two major types: (1) an exudative or “wet” form exhibiting choroidal neovascularization with subretinal exudation (accounting for about 5 % of all AMD cases) and (2) a nonexudative “dry” form accompanied by the formation of retinal drusen (accounting for about 95 % of all AMD cases) [15,…”
An english translation of alzheimer’s 1907 paper, “über eine eigenartige erkankung der hirnrinde”
Stelzmann, R. A., Norman Schnitzlein, H., & Reed Murtagh, F. (1995) · Clinical Anatomy · doi:10.1002/ca.980080612 · Cited by 1,455
Drusen proteome analysis: an approach to the etiology of age-related macular degeneration
Crabb, J. W., Miyagi, M., Gu, X., Shadrach, K., West, K. A., Sakaguchi, H., Kamei, M., Hasan, A., Yan, L., Rayborn, M. E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.222551899 · Cited by 1,208 · cited 3×
“Proteome analysis of drusen shows accumulation of at least 36 proteins with considerable overlap between normal and AMD subjects, suggesting that drusen formation in AMD may be an amplification or intensification of a naturally occurring process [95].”
Autophagy and apoptosis dysfunction in neurodegenerative disorders
Ghavami, S., Shojaei, S., Yeganeh, B., Ande, S. R., Jangamreddy, J. R., Mehrpour, M., Christoffersson, J., Chaabane, W., Moghadam, A. R., Kashani, H. H., et al. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2013.10.004 · Cited by 1,039 · cited 1×
“Currently, there is evidence for at least 14 functions for βAPP, and these include βAPP as (1) a structural regulator of synapse formation [55, 56]; (2) a facilitator of synaptic activity, dendritic spine density, and interneuronal signaling [56, 57]; (3) a neuronal membrane- and synapse-associated factor in neural pl…”
Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives
Mattson, M. P. (1997) · Physiological Reviews · doi:10.1152/physrev.1997.77.4.1081 · Cited by 1,006 · cited 1×
“Currently, there is evidence for at least 14 functions for βAPP, and these include βAPP as (1) a structural regulator of synapse formation [55, 56]; (2) a facilitator of synaptic activity, dendritic spine density, and interneuronal signaling [56, 57]; (3) a neuronal membrane- and synapse-associated factor in neural pl…”
Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.014 · Cited by 1,004
Intramuscular desferrioxamine in patients with Alzheimer's disease
MCLACHLAN, D. (1991) · The Lancet · doi:10.1016/0140-6736(91)92978-b · Cited by 764
Anderson, D. H., Radeke, M. J., Gallo, N. B., Chapin, E. A., Johnson, P. T., Curletti, C. R., Hancox, L. S., Hu, J., Ebright, J. N., Malek, G., et al. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2009.11.003 · Cited by 727
Johnson, L. V., Leitner, W. P., Rivest, A. J., Staples, M. K., Radeke, M. J., & Anderson, D. H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.192203399 · Cited by 447
Lukiw, W. J., Zhao, Y., & Cui, J. G. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m805371200 · Cited by 441
Self-citationAnderson, D. H., Talaga, K. C., Rivest, A. J., Barron, E., Hageman, G. S., & Johnson, L. V. (2004) · Experimental Eye Research · doi:10.1016/j.exer.2003.10.011 · Cited by 319
Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease
Frost, S., Kanagasingam, Y., Sohrabi, H., Vignarajan, J., Bourgeat, P., Salvado, O., Villemagne, V, Rowe, C. C., Lance Macaulay, S., Szoeke, C., et al. (2013) · Translational Psychiatry · doi:10.1038/tp.2012.150 · Cited by 297
Parallel findings in age-related macular degeneration and Alzheimer’s disease
Ohno-Matsui, K. (2011) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2011.02.004 · Cited by 280 · cited 2×
“Lastly, a clearer understanding of the amyloidogenic, pro-inflammatory, and altered innate-immune mechanisms of AD may have strong relevance to AMD retinal biology with the potential implementation of common pharmacological strategies directed toward the treatment and alleviation of each of these progressive, age-rela…”
Zhao, Y., Calon, F., Julien, C., Winkler, J. W., Petasis, N. A., Lukiw, W. J., & Bazan, N. G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0015816 · Cited by 243 · cited 1×
“Aβ42 accumulation is also seen in the retina of AD patients and in transgenic murine models of AD and is currently being developed as an early AD biomarker [46, 76, 94].”
Self-citationAge related macular degeneration and drusen: Neuroinflammation in the retina
Buschini, E., Piras, A., Nuzzi, R., & Vercelli, A. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.05.011 · Cited by 230
TREM2 and the neuroimmunology of Alzheimer's disease
Hickman, S. E., & El Khoury, J. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.11.021 · Cited by 221
Luibl, V. (2006) · Journal of Clinical Investigation · doi:10.1172/jci25843 · Cited by 203
Amyloid precursor protein (APP) regulates synaptic structure and function
Tyan, S.-H., Shih, A. Y.-J., Walsh, J. J., Maruyama, H., Sarsoza, F., Ku, L., Eggert, S., Hof, P. R., Koo, E. H., & Dickstein, D. L. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.07.009 · Cited by 191 · cited 1×
“Currently, there is evidence for at least 14 functions for βAPP, and these include βAPP as (1) a structural regulator of synapse formation [55, 56]; (2) a facilitator of synaptic activity, dendritic spine density, and interneuronal signaling [56, 57]; (3) a neuronal membrane- and synapse-associated factor in neural pl…”
Insights into TREM2 biology by network analysis of human brain gene expression data
Forabosco, P., Ramasamy, A., Trabzuni, D., Walker, R., Smith, C., Bras, J., Levine, A. P., Hardy, J., Pocock, J. M., Guerreiro, R., et al. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.001 · Cited by 180
Variant TREM2 as Risk Factor for Alzheimer's Disease
Neumann, H., & Daly, M. J. (2013) · New England Journal of Medicine · doi:10.1056/nejme1213157 · Cited by 177 · cited 2×
“Aβ42 peptide sensing and clearance may also be accomplished in part through the microglial-enriched transmembrane CD33/Siglec protein and others (see text); interestingly, like TREM2, CD33/Siglec exhibits decreased expression in peripheral mononuclear cells in AD [36, 45].”
Cai, J., Qi, X., Kociok, N., Skosyrski, S., Emilio, A., Ruan, Q., Han, S., Liu, L., Chen, Z., Bowes Rickman, C., et al. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201101084 · Cited by 136 · cited 4×
“type of retinal degeneration involving vascular dysregulation and accumulation of age pigment [97].”
InfluentialRetinal amyloid peptides and complement factor H in transgenic models of Alzheimer's disease
Alexandrov, P. N., Pogue, A., Bhattacharjee, S., & Lukiw, W. J. (2011) · Neuroreport · doi:10.1097/wnr.0b013e3283497334 · Cited by 128
Self-citationThe Role of SORL1 in Alzheimer’s Disease
Yin, R.-H., Yu, J.-T., & Tan, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8742-5 · Cited by 126 · cited 1×
“Signaling via the tyrosine kinasebinding protein (DNAX activation protein 12) [TYROBP (DAP12)] accessory receptor results in phagocytosis and, ultimately, removal of Aβ42 peptides (yellow ovals) from the extracellular space [38–41]; interestingly, TREM2-knockout/knockdownmice have attenuated immunological and inflamma…”
Baker, M. L. (2009) · Archives of Ophthalmology · doi:10.1001/archophthalmol.2009.30 · Cited by 114
Abnormal cleavage of APP impairs its functions in cell adhesion and migration
Sheng, B., Song, B., Zheng, Z., Zhou, F., Lu, G., Zhao, N., Zhang, X., & Gong, Y. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.046 · Cited by 20
Cited by
Deletion of autophagy inducer RB1CC1 results in degeneration of the retinal pigment epithelium
Yao, J., Jia, L., Khan, N., Lin, C., Mitter, S. K., Boulton, M. E., Dunaief, J. L., Klionsky, D. J., Guan, J.-L., Thompson, D. A., et al. (2015) · Autophagy · doi:10.1080/15548627.2015.1041699 · Cited by 130
Pogue, A. I., & Lukiw, W. J. (2018) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-017-0572-3 · Cited by 105
Self-citationLow vision and the risk of dementia: a nationwide population-based cohort study
Paik, J.-S., Ha, M., Jung, Y. H., Kim, G.-H., Han, K.-D., Kim, H.-S., Lim, D. H., & Na, K.-S. (2020) · Scientific Reports · doi:10.1038/s41598-020-66002-z · Cited by 54
Butler, J. M., Sharif, U., Ali, M., McKibbin, M., Thompson, J. P., Gale, R., Yang, Y. C., Inglehearn, C., & Paraoan, L. (2015) · Human Genetics · doi:10.1007/s00439-015-1552-7 · Cited by 28
Metadata
- Authors
- Zhao, Y., Bhattacharjee, S., Jones, B. M., Hill, J. M., Clement, C., Sambamurti, K., Dua, P., & Lukiw, W. J.
- Venue
- Molecular Neurobiology
- Published
- 2014-09-10
- Volume
- 52
- Issue
- 1
- Pages
- 533-544
- ISSN
- 0893-7648 (ISSN-L)
- 1559-1182
- OpenAlex
- W2009744995
- Cited by
- 62
- References
- 25
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.